id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-D-5259-0002,FDA,FDA-2023-D-5259,Master Protocols for Drug and Biological Product Development; Guidance for Industry; Draft Guidance,Other,Guidance,2023-12-22T05:00:00Z,2023,12,2023-12-22T05:00:00Z,2024-03-22T03:59:59Z,2025-11-19T10:00:06Z,,1,0,090000648634c298
FDA-2023-D-5259-0001,FDA,FDA-2023-D-5259,Master Protocols for Drug and Biological Product Development; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2023-12-22T05:00:00Z,2023,12,,,2023-12-22T15:36:56Z,2023-28210,0,0,0900006486351218